Viewing Study NCT01848106


Ignite Creation Date: 2025-12-26 @ 4:02 PM
Ignite Modification Date: 2026-03-04 @ 8:05 AM
Study NCT ID: NCT01848106
Status: TERMINATED
Last Update Posted: 2014-10-23
First Post: 2013-05-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI
Sponsor: Regado Biosciences, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module